MARK LEWIS is Chief Sustainability Strategist at BNP Paribas Asset Management, having joined in January 2019. Previously, he was Managing Director and Head of Research at the Carbon Tracker Initiative (April-December 2018), Managing Director and Head of European Utilities Research at Barclays (2015-18), Chief Energy Economist at Kepler Cheuvreux (2014-15), and Managing Director and Global Head of Energy Research at Deutsche Bank (2005-13). He has also been a member of the Financial Stability Board’s Task Force on Climate-related Financial Disclosures since May 2016.
Mark is a UK and French Citizen and holds a BA (First-Class Hons) in Modern Languages and Economics from Sheffield University, an MPhil from Cambridge University, and an MA from London University.
A highly experienced Senior Director of Clinical Data Systems with considerable global experience within the CRO and technology environments. Key experiences are within the US, Indian and all European markets across all phases and multiple therapeutic areas. Well versed in GDPR, validation, and regulatory requirements across US and EU markets.
Ian is an independent consultant with expertise in regulatory and scientific aspects of nicotine and tobacco products. His current consulting work focusses on advising manufacturers on regulatory requirements for e-cigarettes as both consumer goods and medicinally-licensed products, in the US, UK and Europe. His consulting work also provides human studies services to companies, including clinical and behavioural studies. Prior to independent consulting, Ian worked for JUUL Labs as Senior Director of Clinical and Regulatory Affairs EMEA, and previously he was Director of Tobacco Research at Celerion, a provider of clinical research capabilities and regulatory expertise to the tobacco and e-cigarette industries. Prior to that, Ian was Principal Scientist and Head of Clinical Research at British American Tobacco’s central research and development centre in Southampton, U.K. He specializes in the biological and psychological effects of nicotine, , clinical and behavioural studies to assess the individual and population impact of electronic cigarettes and tobacco heating devices, and the scientific basis for regulation. Prior to working in the industry, Ian pursued an academic career as a Lecturer in Physiology at the University of Manchester and an Assistant Professor in Biology at McMaster University in Hamilton, Canada. Ian is a highly-cited scientific researcher and writer, contributing to more than 50 peer-reviewed papers and book chapters which have generated over 2,900 citations.
Beenu Kapoor is a creator of platform technology products leveraging her Business Operations, IT, Product Development and Consulting skills to augment digital transformation in R&D Clinical Development. Beenu has more than 25 years of experience focused on driving business outcomes by defining and implementing strategies, roadmaps, solutions involving innovative business operating models, process redesign and technology digitization agenda. She is currently serving as a leader on the IQVIA Technology team responsible for IQVIA’s Trial Management Product Suite
